Singapore, March 10 -- A new 'nanoball' vaccine platform developed by experts in Japan will be tested as part of new research, supported by Norway-basedCoalition for Epidemic Preparedness Innovations (CEPI), looking for promising tools that could help fight an infectious disease outbreak with pandemic potential.

Researchers at Nagasaki University have developed the pioneering innovation as a novel approach to aid the delivery of messenger RNA (mRNA) vaccines in the body.

With up to $5 million in new funding from CEPI, the Nagasaki team will conduct preclinical studies to investigate whether their next-generation technology, where the mRNA is instead encased in nano-sized, negatively-charged particles, could overcome challenges and confr...